SA PRO
Free Account
The Oncology Institute, Inc.TOINASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
3 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
3100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 104% higher.

Bear Case
$5.00
+104%
Consensus
$5.00
+104%
Bull Case
$5.00
+104%
Price Range3 analysts
Low
Consensus
High
$5.00
$5.00
Current Target
Current Price
$2.45
Upside to Target
$2.55

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 25, 2025Needham
Oncology Institute initiated with a Buy at Needham
Target:$5.00
+64.5%from $3.04
Nov 11, 2022Guggenheim
Guggenheim Maintains Buy on The Oncology Institute, Lowers Price Target to $6
Target:$6.00
+140.1%from $2.50
Aug 15, 2022Jefferies
Jefferies Initiates Coverage On The Oncology Institute with Buy Rating, Announces Price Target of $10
Target:$10.00
+55.3%from $6.44

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance